Real-world outcomes with lomitapide use in paediatric patients with homozygous familial hypercholesterolaemia (2019)
- Authors:
- Autor USP: SANTOS FILHO, RAUL DIAS DOS - FM
- Unidade: FM
- DOI: 10.1007/s12325-019-00985-8
- Subjects: CARDIOLOGIA; LIPOPROTEÍNAS; PEDIATRIA; HIPERCOLESTEROLEMIA
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Advances in therapy
- ISSN: 0741-238X
- Volume/Número/Paginação/Ano: v. 36, n. 7, p. 1786-1811, 2019
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
BEN-OMRAN, Tawfeg et al. Real-world outcomes with lomitapide use in paediatric patients with homozygous familial hypercholesterolaemia. Advances in therapy, v. 36, n. 7, p. 1786-1811, 2019Tradução . . Disponível em: https://doi.org/10.1007/s12325-019-00985-8. Acesso em: 23 jan. 2026. -
APA
Ben-omran, T., Masana, L., Kolovou, G., Ariceta, G., Novoa, F. J., Lund, A. M., et al. (2019). Real-world outcomes with lomitapide use in paediatric patients with homozygous familial hypercholesterolaemia. Advances in therapy, 36( 7), 1786-1811. doi:10.1007/s12325-019-00985-8 -
NLM
Ben-omran T, Masana L, Kolovou G, Ariceta G, Novoa FJ, Lund AM, Bogsrud MP, Araujo M, Hussein O, Santos Filho RD dos. Real-world outcomes with lomitapide use in paediatric patients with homozygous familial hypercholesterolaemia [Internet]. Advances in therapy. 2019 ; 36( 7): 1786-1811.[citado 2026 jan. 23 ] Available from: https://doi.org/10.1007/s12325-019-00985-8 -
Vancouver
Ben-omran T, Masana L, Kolovou G, Ariceta G, Novoa FJ, Lund AM, Bogsrud MP, Araujo M, Hussein O, Santos Filho RD dos. Real-world outcomes with lomitapide use in paediatric patients with homozygous familial hypercholesterolaemia [Internet]. Advances in therapy. 2019 ; 36( 7): 1786-1811.[citado 2026 jan. 23 ] Available from: https://doi.org/10.1007/s12325-019-00985-8 - Does nonalcoholic fatty liver disease cause cardiovascular disease? Current knowledge and gaps
- Characterizing familial chylomicronemia syndrome: baseline data of the APPROACH study
- Sex disparity in the management and outcomes of dyslipidemia of diabetic patients in the Arabian Gulf: findings from the CEPHEUS study
- Vertebral bone density by quantitative computed tomography mirrors bone structure histomorphometric parameters in hemodialysis patients
- Effects of medication, treatment, and behavioral beliefs on intentions to take medication in patients with familial hypercholesterolemia
- Increased subclinical atherosclerosis burden in familial hypercholesterolemia phenotype [Editorial]: What do genetic defects tell us and what are the clinical implications?
- Sodium intake and prevalence of hypertension in elementary school students
- Clinical Genetic Testing for Familial Hypercholesterolemia
- Cardiovascular event reduction with PCSK9 inhibition among 1578 patients with familial hypercholesterolemia: results from the SPIRE randomized trials of bococizumab
- Genetics and molecular biology controversies on Mendelian randomization and proprotein convertase subtilisin-kexin type 9 inhibitor clinical trials [Editorial]: more data still necessary
Informações sobre o DOI: 10.1007/s12325-019-00985-8 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
